Seres Therapeutics, Inc. (MCRB)

Last Closing Price: 1.00 (2024-05-31)

Consolidated Net Income/Loss (Annual)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

Seres Therapeutics, Inc. (MCRB) had Consolidated Net Income/Loss of $-113.72M for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$126.33M
$-113.72M
--
$126.33M
$234.31M
$-107.98M
$-5.74M
$-113.72M
$-113.72M
$-113.72M
$-113.72M
Consolidated Net Income/Loss
$-113.72M
$-113.72M
$-107.98M
$-100.84M
128.00M
128.00M
$-0.89
$-0.89
Balance Sheet Financials
$175.41M
$22.46M
$183.19M
$358.60M
$98.66M
$101.54M
$304.80M
$403.46M
$-44.86M
$-44.86M
$-44.86M
135.04M
Cash Flow Statement Financials
$-117.35M
$10.58M
$71.70M
$171.22M
$136.15M
$-35.07M
$34.10M
--
--
Fundamental Metrics & Ratios
1.78
--
--
1.79
-2.26
100.00%
-85.48%
-85.48%
-79.82%
-90.02%
-90.02%
$-125.33M
--
--
--
0.35
--
14.56
25.06
253.53%
253.53%
-31.71%
-200.61%
$-0.33
$-0.98
$-0.92